About This Event
Vir Biotechnology (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer, visits the Nasdaq MarketSite in Times Square to celebrate a decade of scientific innovation.
In honor of the occasion, Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and President rings the Closing Bell.